Brevan Howard Capital Management LP Sells 12,453 Shares of Henry Schein, Inc. $HSIC

Brevan Howard Capital Management LP lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 22.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,224 shares of the company’s stock after selling 12,453 shares during the period. Brevan Howard Capital Management LP’s holdings in Henry Schein were worth $2,869,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. CYBER HORNET ETFs LLC bought a new position in Henry Schein during the 2nd quarter worth about $25,000. MUFG Securities EMEA plc purchased a new position in Henry Schein during the 2nd quarter valued at about $27,000. Sentry Investment Management LLC raised its holdings in shares of Henry Schein by 132.1% in the 3rd quarter. Sentry Investment Management LLC now owns 905 shares of the company’s stock valued at $59,000 after purchasing an additional 515 shares in the last quarter. Evelyn Partners Investment Management Services Ltd purchased a new stake in shares of Henry Schein in the 2nd quarter worth approximately $62,000. Finally, Mather Group LLC. purchased a new stake in shares of Henry Schein in the 3rd quarter worth approximately $71,000. 96.62% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Kurt P. Kuehn sold 2,844 shares of the firm’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $78.96, for a total value of $224,562.24. Following the completion of the sale, the director owned 15,420 shares of the company’s stock, valued at $1,217,563.20. This trade represents a 15.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Mark E. Mlotek sold 5,925 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $80.80, for a total value of $478,740.00. Following the transaction, the executive vice president owned 80,554 shares in the company, valued at approximately $6,508,763.20. This trade represents a 6.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 104,556 shares of company stock worth $8,476,351. 1.14% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Wall Street Zen lowered shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a report on Saturday. JPMorgan Chase & Co. upped their target price on Henry Schein from $78.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, February 25th. Wells Fargo & Company increased their target price on Henry Schein from $76.00 to $87.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 25th. Barrington Research set a $97.00 price target on Henry Schein and gave the company an “outperform” rating in a report on Wednesday, February 25th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Henry Schein in a research report on Monday, December 29th. Six research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Henry Schein currently has a consensus rating of “Hold” and an average price target of $85.58.

Henry Schein Trading Down 1.3%

NASDAQ HSIC opened at $74.61 on Tuesday. The company has a quick ratio of 0.76, a current ratio of 1.38 and a debt-to-equity ratio of 0.59. The firm has a market cap of $8.56 billion, a PE ratio of 22.82, a price-to-earnings-growth ratio of 2.24 and a beta of 0.87. The company has a 50 day moving average price of $78.13 and a 200 day moving average price of $72.93. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $89.29.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 24th. The company reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.04. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The company had revenue of $3.44 billion during the quarter, compared to analysts’ expectations of $3.34 billion. During the same quarter in the prior year, the company posted $1.19 earnings per share. Henry Schein’s revenue for the quarter was up 7.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.